Can Genetic Testing Predict Athletic Performance?

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Peptides & GLP-1. Browse all Peptides & GLP-1 education

It’s one of the most searched questions in the sport genetics space — and one that deserves a precise answer rather than a marketing one. Can genetic testing predict athletic performance? The honest answer is: not in the deterministic sense people usually mean. Genetics cannot tell you whether you’ll make the Olympics, win a powerlifting meet, or outrun a competitor. What it can do — and what the Precision Peptide Genetic Test specifically does — is reveal the biological architecture your training response is built on, across 14 pathways, 49 peptides, and 150+ genetic insights. That’s a more useful thing to know.

What Genetic Testing Cannot Do for Athletic Performance

Athletic performance is one of the most complex polygenic phenotypes in human biology. Research consistently shows it is influenced by thousands of genetic variants, each contributing a small effect, compounded by training history, coaching quality, psychological drive, nutrition, sleep, and environmental opportunity. No single gene — and no current panel of genes — can predict athletic outcomes with the reliability implied by phrases like “genetic potential test” or “DNA athletic profile.”

Studies estimating the heritability of specific athletic traits find wide ranges: VO₂max trainability has been estimated at roughly 47% heritable in twin studies (Bouchard et al.); sprint performance heritability estimates range from 50–70% depending on the trait measured. That means 30–53% of the variance is environmental — training, recovery, coaching, and dedication. Genetics sets a range of possible outcomes; it does not select one. Any test that claims otherwise is overstating the science.

The Precision Peptide Genetic Test does not claim to predict athletic performance or outcomes. It does not tell you whether you should pursue a sport, which events you should compete in, or whether you have “elite” genetics. Those claims would not be supported by the evidence — and they are not what the test delivers.

What Genetic Testing CAN Reveal: The Biological Architecture View

What genetic testing can do — and what the research actually supports — is reveal specific, documented biological predispositions that shape how your body responds to training stimulus. These aren’t predictions of outcomes; they’re maps of the starting conditions. The difference matters:

ACTN3 R577X — fiber type composition: Whether your muscle fiber architecture skews fast-twitch (RR: power and hypertrophy-optimized) or slow-twitch (XX: endurance and recovery-optimized). This doesn’t determine whether you’ll be a sprinter or a marathoner — it reveals the fiber foundation that your chosen training will build on.

ACE I/D — cardiovascular architecture: Whether your vascular physiology is optimized for oxygen delivery efficiency (II: endurance) or for vasoconstriction and explosive output (DD: power). Together with ACTN3, ACE describes the endurance–power spectrum your cardiovascular and neuromuscular systems naturally favor.

MSTN — hypertrophy ceiling: How actively your body suppresses muscle mass accumulation. A higher-myostatin-activity MSTN genotype doesn’t prevent muscle growth — it means the ceiling is tighter and periodization matters more than raw training volume.

IGF1 and GHSR — anabolic signal capacity: How efficiently your GH→IGF-1 axis generates and translates the primary anabolic signal. This shapes recovery speed and the magnitude of the hypertrophic response to equivalent training load.

IL-6 — recovery genetics: How vigorously your body initiates repair between training sessions. GG genotype carriers generate a stronger per-session recovery signal but carry a higher inflammatory load; CC carriers recover faster and tolerate higher frequency with lower soreness.

None of these findings predict outcomes. Each one reveals a biological starting point that makes training design and healthcare provider conversations more informed and specific.

The Sport Genetics Research Record

The two most replicated findings in sport genetics are both in the Precision Peptide Genetic Test panel — and they illustrate exactly what the field can and cannot support:

The ACTN3 R577X finding (Yang et al., 2003) established that XX genotype — producing no functional alpha-actinin-3 — is significantly underrepresented among elite power athletes while overrepresented among elite endurance athletes. This is one of the most robust population-level associations in sport genetics. What it does not do is predict individual athletic outcomes: XX genotype individuals have competed at the highest levels of power sports, and RR individuals have excelled in endurance. The gene describes a population tendency, not an individual ceiling.

The ACE I/D finding (Montgomery et al., 1998; Williams et al., 2000) similarly shows that I allele is overrepresented in elite endurance athletes and D allele overrepresented in elite power athletes across multiple independent cohorts. Again — a population-level pattern, not an individual prediction. The practical utility is in training design: knowing whether your cardiovascular physiology naturally favors endurance or power optimization helps you build training that complements rather than fights your biology.

Polygenic scoring research is attempting to combine hundreds of variants into composite scores for athletic traits — but these models currently explain only a small fraction of performance variance in humans and are not validated for individual prediction. The field is advancing, but the honest current state is: population-level genetic associations are well-established for several traits; individual-level prediction is not.

What This Means for Training, Recovery, and Protocol Conversations

The right frame for genetic testing in an athletic context is not “what will I achieve?” but “what am I working with?” Your ACTN3 genotype tells you what fiber architecture your training lands on. Your ACE genotype tells you which direction your cardiovascular physiology naturally optimizes. Your MSTN genotype tells you how tight your hypertrophy ceiling is. Your IGF1 and GHSR genotypes tell you how loud your anabolic signal fires. Your IL-6 genotype tells you how quickly your recovery system processes training load.

None of that is prediction. All of it is genuinely useful biology — the kind that changes which training periodization makes sense, how much recovery is actually required between sessions, and what realistic expectations look like for growth hormone axis pathway conversations with a healthcare provider. Test before you invest applies here exactly: genetics as a guide, not a guarantee, informing decisions rather than making them.

The Precision Peptide Genetic Test analyzes how your genes influence muscle growth pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to map the biological architecture your athletic training is built on? Take the Precision Peptide Genetic Test

Frequently Asked Questions About Genetic Testing and Athletic Performance

Can genetic testing predict athletic performance?

Not precisely — genetic testing cannot predict athletic outcomes or guarantee elite performance. What it reveals is biological architecture: fiber type (ACTN3), cardiovascular optimization direction (ACE), anabolic capacity (IGF1, GHSR), and recovery genetics (IL-6). The Precision Peptide Genetic Test delivers 15 Muscle Growth insights that inform training and healthcare conversations, not talent predictions.

What does genetic testing actually reveal about sports performance?

Genetic testing reveals biological predispositions that shape training response — not outcomes. ACTN3 R577X determines fast-twitch versus slow-twitch fiber composition; ACE I/D reveals cardiovascular optimization direction; MSTN variants reveal hypertrophy ceiling; IGF1 and GHSR variants reveal anabolic signal capacity. These findings are most useful for training design and healthcare provider conversations, not selection or prediction.

Is ACTN3 testing worth it for athletic performance?

ACTN3 R577X is among the most replicated findings in sport genetics — revealing whether muscle fiber composition skews fast-twitch (RR: power/hypertrophy) or slow-twitch (XX: endurance/recovery). The Precision Peptide Genetic Test analyzes ACTN3 alongside MSTN, IGF1, ACE, VDR, and IL-6 across 15 Muscle Growth insights — architecture context, not a single gene snapshot.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.